RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Kirken, Robert
PropertyValue
overview The goal of the laboratory is to understand the intracellular signaling pathways responsible for mediating T cell activation so that rational strategies to regulate immune responses can be achieved. To accomplish this objective it is necessary to first understand the mechanisms through which these cells are activated. It is clear that T cell activation requires engagement with antigen, costimulatory molecules, and intercellular signaling peptides called cytokines. One cytokine we are particularly interested in is interleukin 2 (IL2). IL2 belongs to a family of cytokines that utilize a shared receptor subunit referred to as the IL2 receptor common gamma (g) chain, or gc. This receptor is recruited by one of several cytokines, which then activate a select member of the Janus tyrosine Kinase (JAK) family, JAK3. JAK3 plays a key role in the development and function of T cells. However, the intracellular molecules activated by JAK3 are not readily known nor the genes it regulates. Therefore, the laboratory is focused on identifying and characterizing these signaling proteins to better understand this event. We are particularly interested in a family of gene regulating molecules known as signal transducers and activators of transcription (Stats) and several ongoing studies in the laboratory are examining the role that Stat5a and Stat5b perform in regulating T cell activity and disease. Through critical analysis of these signaling pathways it will be possible to utilize pharmaceuticals to manipulate these secondary messengers and subsequently modulate an immune response. Ultimately, these studies will enable us to develop novel immunomodulatory drugs with therapeutic potential against important clinical conditions such as cancer, graft-versus-host disease, allergy, and autoimmune disorders
One or more keywords matched the following items that are connected to Kirken, Robert
Item TypeName
Academic Article Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells.
Academic Article Analysis of Janus tyrosine kinase phosphorylation and activation.
Academic Article Activation of receptor-associated tyrosine kinase JAK2 by prolactin.
Academic Article Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase.
Academic Article Inhibition of Jak3 tyrosine kinase by PNU156804 blocks rat heart allograft rejection.
Academic Article PNU156804 inhibits Jak3 tyrosine kinase and rat heart allograft rejection.
Academic Article The role of Stat5 in the induction of regulatory T cells in transplantation tolerance.
Academic Article Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin.
Academic Article Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Concept Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
Concept ZAP-70 Protein-Tyrosine Kinase
Academic Article Structural Analysis of Janus Tyrosine Kinase Variants in Hematological Malignancies: Implications for Drug Development and Opportunities for Novel Therapeutic Strategies.
Search Criteria
  • TYK2 Kinase
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support